Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Chemical Communications (Cambridge, England)
|
June 8, 2010
Hairpin DNA coated gold nanoparticles as intracellular mRNA probes for the detection of tyrosinase gene expression in melanoma cells
S Reese Harry, Donna J Hicks, Katayoun I Amiri, et al.
Journal of Biochemical and Biophysical Methods
|
March 1, 1985
A home-made solid-phase sequencer operating at the nanomole level
I Amiri, J Neimark, A Waltz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 10, 2006
BMS-345541 targets inhibitor of kappaB kinase and induces apoptosis in melanoma: involvement of nuclear factor kappaB and mitochondria pathways
Jinming Yang, Katayoun I Amiri, James R Burke, et al.
Cancer Research
|
July 17, 2004
Augmenting chemosensitivity of malignant melanoma tumors via proteasome inhibition: implication for bortezomib (VELCADE, PS-341) as a therapeutic agent for malignant melanoma
Katayoun I Amiri, Linda W Horton, Bonnie J LaFleur, et al.
Biochimica Et Biophysica Acta
|
April 8, 1991
The complete amino acid sequence of the pathogenesis-related (PR2) protein induced in chemically stressed bean leaves
A Awade, M H Metz-Boutigue, M Le Ret, et al.
Brain Research
|
April 19, 1988
gamma-L-glutamyl-L-aspartate induces specific deficits in long-term memory and inhibits [3H]glutamate binding on hippocampal membranes
A Ungerer, M Schmitz-Bourgeois, C Mélan, et al.
Journal of Research in Health Sciences
|
January 25, 2013
L-carnitine level in seminal plasma of fertile and infertile men
N Sheikh, Mt Goodarzi, H Bab Al-Havaejee, et al.
Journal of Chromatography
|
May 5, 1989
Clostridium difficile toxin B: characterization and sequence of three peptides
F Bisseret, G Keith, B Rihn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 24, 2009
A phase I trial of bortezomib with temozolomide in patients with advanced melanoma: toxicities, antitumor effects, and modulation of therapeutic targets
Yingjun Su, Katayoun I Amiri, Linda W Horton, et al.
Investigational New Drugs
|
June 4, 2014
Phase II trial of bortezomib plus doxorubicin in hepatocellular carcinoma (E6202): a trial of the Eastern Cooperative Oncology Group
Kristen K Ciombor, Yang Feng, Al Bowen Benson, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Chemical Communications (Cambridge, England)
|
June 8, 2010
Hairpin DNA coated gold nanoparticles as intracellular mRNA probes for the detection of tyrosinase gene expression in melanoma cells
S Reese Harry, Donna J Hicks, Katayoun I Amiri, et al.
Journal of Biochemical and Biophysical Methods
|
March 1, 1985
A home-made solid-phase sequencer operating at the nanomole level
I Amiri, J Neimark, A Waltz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 10, 2006
BMS-345541 targets inhibitor of kappaB kinase and induces apoptosis in melanoma: involvement of nuclear factor kappaB and mitochondria pathways
Jinming Yang, Katayoun I Amiri, James R Burke, et al.
Cancer Research
|
July 17, 2004
Augmenting chemosensitivity of malignant melanoma tumors via proteasome inhibition: implication for bortezomib (VELCADE, PS-341) as a therapeutic agent for malignant melanoma
Katayoun I Amiri, Linda W Horton, Bonnie J LaFleur, et al.
Biochimica Et Biophysica Acta
|
April 8, 1991
The complete amino acid sequence of the pathogenesis-related (PR2) protein induced in chemically stressed bean leaves
A Awade, M H Metz-Boutigue, M Le Ret, et al.
Brain Research
|
April 19, 1988
gamma-L-glutamyl-L-aspartate induces specific deficits in long-term memory and inhibits [3H]glutamate binding on hippocampal membranes
A Ungerer, M Schmitz-Bourgeois, C Mélan, et al.
Journal of Research in Health Sciences
|
January 25, 2013
L-carnitine level in seminal plasma of fertile and infertile men
N Sheikh, Mt Goodarzi, H Bab Al-Havaejee, et al.
Journal of Chromatography
|
May 5, 1989
Clostridium difficile toxin B: characterization and sequence of three peptides
F Bisseret, G Keith, B Rihn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 24, 2009
A phase I trial of bortezomib with temozolomide in patients with advanced melanoma: toxicities, antitumor effects, and modulation of therapeutic targets
Yingjun Su, Katayoun I Amiri, Linda W Horton, et al.
Investigational New Drugs
|
June 4, 2014
Phase II trial of bortezomib plus doxorubicin in hepatocellular carcinoma (E6202): a trial of the Eastern Cooperative Oncology Group
Kristen K Ciombor, Yang Feng, Al Bowen Benson, et al.
Page
of 3